Empagliflozin reduces adverse cardiovascular events in type 2 diabetes patients Dr. Prem Aggarwal16 May 2016 3:02 PM ISTEmpagliflozin is a drug of gliflozin class, approved for the treatment of type 2 diabetes in adults in 2014. Empagliflozin is an inhibitor of the...
Empagliflozin (zardiance) good in Diabetes with CVD and CKD Dr. Kamal Kant Kohli Kohli25 Sept 2017 10:30 AM ISTNew analyses of the landmark EMPA-REG OUTCOME®trial showed that Empagliflozin improved clinical outcomes and reduced mortality in vulnerable patients...
Empagliflozin decreases on risk Of CV Death and HF hospitalization Dr. Prem Aggarwal19 Oct 2017 7:32 PM ISTDiabetes has been found to be associated with increased risk of cardiovascular death and heart failure. Diabetic patients get increased incidence of...
Empagliflozin may help in treating Nonalcoholic Fatty Liver Disease : E-LIFT Trial Anjali Nimesh Nimesh20 March 2018 8:00 PM ISTNonalcoholic fatty liver disease (NAFLD) is common and can progress to a severe liver disease known as nonalcoholic steatohepatitis (NASH) in people...
SGLT-2 inhibitors best for lowering mortality risk in T2DM : JAMA Dr. Kamal Kant Kohli Kohli22 April 2018 8:00 PM ISTThe comparative clinical efficacy of sodium-glucose cotransporter 2 (SGLT-2) inhibitors, glucagon-like peptide 1 (GLP-1) agonists, and dipeptidyl...
Oral semaglutide better than empagliflozin in improving HbA1c -PIONEER 2 trial Vinay Singh singh3 Jun 2018 8:25 PM ISTTreatment with oral semaglutide 14mg led to a statistically significant improvement in hemoglobin A1c (HbA1c) levels and weight loss in adults with...
Empagliflozin does not increase bone fracture risk in diabetes patients Medha Baranwal Baranwal23 July 2018 8:20 PM ISTA new study published in the journal Diabetes Care finds that Empagliflozin -- a drug given for the treatment of type 2 diabetes (T2D) -- does not...
SGLT2 inhibitors may cause Fournier's gangrene of genital area in diabetics : FDA warns Hina Zahid31 Aug 2018 8:35 PM ISTThe Food and Drug Administration (FDA) has issued a warning regarding serious genital infection known as Fournier's gangrene that has been reported in...
Diabetes medications linked to increased risk of amputation Medha Baranwal Baranwal19 Nov 2018 7:28 PM ISTType 2 diabetes (T2D) patients treated with sodium-glucose cotransporter 2 (SGLT2) inhibitors have an increased risk of lower-limb amputation and...
New Therapies for risk reduction in Diabetes with CVD: ACC guidance Medha Baranwal Baranwal29 Nov 2018 7:00 PM ISTThe American College of Cardiology has released new guidance on novel therapies for reduction of cardiovascular (CV) risk in patients with...
Empagliflozin may reverse heart failure in non-diabetic patients, finds study Deepanjana Sarkar21 April 2019 7:28 PM ISTA new anti-diabetic drug " empagliflozin" may reverse progressing heart failure in patients who do not have diabetes, pointed out a new study...
Semaglutide reduces cardiac events in high risk diabetics: PIONEER 6 trial Hina Zahid13 Jun 2019 8:28 PM ISTOral Semaglutide reduces cardiac events in high-risk diabetics reveal results of PIONEER 6 trial.According to results of the PIONEER 6 trial announced...
